Leslie J. Williams's most recent trade in Ocular Therapeutix Inc was a trade of 44,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ocular Therapeutix Inc | Leslie J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Leslie J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 14,000 | 51,433 (0%) | 0% | 0 | Common Stock | |
| Ocular Therapeutix Inc | Leslie J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2024 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Leslie J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2024 | 12,000 | 37,433 (0%) | 0% | 0 | Common Stock | |
| Windtree Therapeutics Inc | Leslie J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 3,050 | 3,050 | - | - | Stock Option (Right to Buy) | |
| Windtree Therapeutics Inc | Leslie J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 2,033 | 2,133 (0%) | 0% | 0 | Common Stock | |
| Ocular Therapeutix Inc | Leslie J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Leslie J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 12,000 | 25,433 (0%) | 0% | 0 | Common Stock | |
| Ocular Therapeutix Inc | Leslie J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 26,800 | 26,800 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Leslie J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 8,933 | 13,433 (0%) | 0% | 0 | Common Stock | |
| Windtree Therapeutics Inc | Leslie J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 7,500 | 7,500 | - | - | Stock Option (Right to Buy) | |
| Windtree Therapeutics Inc | Leslie J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 5,000 | 5,000 (0%) | 0% | 0 | Common Stock | |
| Ocular Therapeutix Inc | Leslie J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Windtree Therapeutics Inc | Leslie J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) |